Status:
RECRUITING
HIV and Changes in the Gut Microbiome After Changes in Antiretroviral Therapy (ART)
Lead Sponsor:
University of Manchester
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
This is a study that aims to contribute to the understanding of how antiretroviral therapy effects the gut microbiome which, if known, could inform decisions about drug choices at an individual level....
Eligibility Criteria
Inclusion
- Aged ≥18 years.
- Willing to undergo stool sample collection on two occasions.
- Able to give written, informed consent.
- Have evidence of HIV infection
- Have been on stable antiretroviral treatment for the previous ≥12months.
- Planning to switch ART regimen from one class of drugs or delivery method to another.
Exclusion
- HIV viral load \>50 copies/ml blood
Key Trial Info
Start Date :
May 17 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06100211
Start Date
May 17 2024
End Date
May 1 2025
Last Update
January 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester University NHS Foundation Trust
Manchester, Greater Manchester, United Kingdom, M13 9WL